The picture would change when studies began to appear in medical journals some five years ago describing an increased incidence of atypical femur fractures in patients taking these drugs for an extended period of time. Since these fractures also appear in patients not taking bisphosphonates, it is unclear whether the drugs are the cause. [...] individuals were advised further to register any adverse effects from bisphosphonates to the FDA's Med Watch Reporting Program.
Pages to are hidden for
"Osteoporosis Drugs' "Broken" Promise"Please download to view full document